Vol 87, No 3 | The Journal of Clinical Psychiatry

Meta-Analysis

Systematic Review and Meta-Analysis of Mood Stabilizers in the Treatment of Adolescent Patients With Nonsuicidal Self-Injury in China

J Clin Psychiatry 2026;87(3):25r16158

Weidong Jin, MD; Zhehao Chen, MM; Haihan Chen, MM; Letian Di, MM; Fengli Sun, MD

Original Research

The Effect of a Nationwide Aftercare Program for Self-Harm Presentations on the Risk of Self-Harm Repetition and Suicide: A Cohort Study

J Clin Psychiatry 2026;87(3):25m16173

Chien-Yu Lin, PhD; Yi-Han Chang, PhD; Chia-Yueh Hsu, PhD; Ying-Yeh Chen, ScD; Chi-Shin Wu, PhD; Chau-Shoun Lee, PhD; Shu-Sen Chang, PhD

Original Research

National Trends in Posttraumatic Stress Disorder Among US Military Veterans: Results From the 2025–2026 National Health and Resilience in Veterans Study

J Clin Psychiatry 2026;87(3):26m16378

Robert H. Pietrzak, PhD, MPH; Ian C. Fischer, PhD; Peter J. Na, MD, MPH; Ilan Harpaz-Rotem, PhD; Ismene L. Petrakis, MD; John H. Krystal, MD

Original Research

Inhaled Mebufotenin (GH001) for Adult Patients With Postpartum Depression: A Phase 2a Open-Label Clinical Trial

J Clin Psychiatry 2026;87(3):25m16284

Martin Johnson, MB, ChB, MRCGP; Pau Aceves Baldo, MSc; Emilio Arbe, MD; Brian Brennan, PhD; Sem E. Cohen, MD; Kelly Doolin, PhD; William Gann, MbChb; David Gregory, MBBS; Sarah Keady, PhD; Katerina Kriger, BA; Rachael MacIsaac, PhD; Stuart Ratcliffe, MBChB; David R. Rubinow, MD; Claus Bo Svendsen, MD PhD MBA; Theis H. Terwey, PD Dr med; Dan Tully, MBBS; Velichka Valcheva, MD, MSc; Jasper B. Zantvoord, MD, PhD; Kristina M. Deligiannidis, MD

Original Research ▶ Video

County-Level Variation in Substance Use Disorder Service Utilization by Insurance Payers and Self-Pay in the United States

J Clin Psychiatry 2026;87(3):26m16340

Beth Han, PhD, MD, MPH; Wilson M. Compton, MD, MPE; Christopher M. Jones, PharmD, DrPH, MPH; Daniel T. Stimson, JD, PhD; Elizabeth T. Barfield, PhD; Julie Frost Bellgowan, MS; Jennifer A. Hobin, PhD; Nora D. Volkow, MD

Original Research ▶ Video

Hallucinogen-Psychosis Associations Are Confounded by Baseline Psychiatric History

J Clin Psychiatry 2026;87(3):25m16034

Jacob T. Steinle, MD; Suraj Shankar, MD; Joshua S. Siegel, MD PhD; Leopoldo J. Cabassa, PhD MSW; Danielle R. Adams, PhD LMSW; Patricia Cavazos-Rehg, PhD; Arpana Agrawal, PhD; Ginger E. Nicol, MD; Richard Grucza, PhD; Kevin Y. Xu, MD MPH

Commentary

Prescribing GLP-1 Receptor Agonists for Persons With Mental Disorders: Evidence-Based and Aspirational Targets

J Clin Psychiatry 2026;87(3): 26com16484.

Roger S. McIntyre, MD, FRCPC

ASCP Corner

Catatonia as a Case Study in Psychiatric Decision-Making

J Clin Psychiatry 2026;87(3):26ac16389

Rachel L. MacLean, MD; Joseph B. Stoklosa, MD

Brief Report

Prevalence of GLP-1 Receptor Agonist Use Among Privately Insured Individuals With Mood Disorders

J Clin Psychiatry 2026;87(3):26br16352

Mason T. Breitzig, PhD; Tyler R. Trippetti, MPH; Lan Kong, PhD; Erika F. H. Saunders, MD; Andrew A. Nierenberg, MD; Guodong Liu, PhD

Volume 87 • 2026 • 3

Meta-Analysis

Systematic Review and Meta-Analysis of Mood Stabilizers in the Treatment of Adolescent Patients With Nonsuicidal Self-Injury in China

Original Research

The Effect of a Nationwide Aftercare Program for Self-Harm Presentations on the Risk of Self-Harm Repetition and Suicide: A Cohort Study

National Trends in Posttraumatic Stress Disorder Among US Military Veterans: Results From the 2025–2026 National Health and Resilience in Veterans Study

Inhaled Mebufotenin (GH001) for Adult Patients With Postpartum Depression: A Phase 2a Open-Label Clinical Trial

County-Level Variation in Substance Use Disorder Service Utilization by Insurance Payers and Self-Pay in the United States

Hallucinogen-Psychosis Associations Are Confounded by Baseline Psychiatric History

Commentary

Prescribing GLP-1 Receptor Agonists for Persons With Mental Disorders: Evidence-Based and Aspirational Targets

ASCP Corner

Catatonia as a Case Study in Psychiatric Decision-Making

Brief Report

Prevalence of GLP-1 Receptor Agonist Use Among Privately Insured Individuals With Mood Disorders

ELSEWHERE:

FOLLOW US:

Volume 87 • 2026 • 3

Meta-Analysis

Systematic Review and Meta-Analysis of Mood Stabilizers in the Treatment of Adolescent Patients With Nonsuicidal Self-Injury in China

Original Research

The Effect of a Nationwide Aftercare Program for Self-Harm Presentations on the Risk of Self-Harm Repetition and Suicide: A Cohort Study

National Trends in Posttraumatic Stress Disorder Among US Military Veterans: Results From the 2025–2026 National Health and Resilience in Veterans Study

Inhaled Mebufotenin (GH001) for Adult Patients With Postpartum Depression: A Phase 2a Open-Label Clinical Trial

County-Level Variation in Substance Use Disorder Service Utilization by Insurance Payers and Self-Pay in the United States

Hallucinogen-Psychosis Associations Are Confounded by Baseline Psychiatric History

Commentary

Prescribing GLP-1 Receptor Agonists for Persons With Mental Disorders: Evidence-Based and Aspirational Targets

ASCP Corner

Catatonia as a Case Study in Psychiatric Decision-Making

Brief Report

Prevalence of GLP-1 Receptor Agonist Use Among Privately Insured Individuals With Mood Disorders

Insightful. Evidence-based. Human-centered.

Subscribe to readmore articles

Subscribe to read
more articles